Detected ·
Orizuru Therapeutics, Inc.
¥300M—
Orizuru Therapeutics, Inc., a Kyoto University-originated biotech developing iPS cell-derived therapies for heart failure and type 1 diabetes, received an additional investment of approximately JPY 300 million from Kyoto University Innovation Capital Co., Ltd.
- Website
- orizuru-therapeutics.com
- Amount
- ¥300 000 000 JPY
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-07 12:03:45 UTC
- Signal ID
- faa5903c-0d1a-4406-84f8-06cbbdcac8cb
As the API returns it
{
"id": "faa5903c-0d1a-4406-84f8-06cbbdcac8cb",
"created_at": "2026-08-07T12:03:45.959196Z",
"company_name": "Orizuru Therapeutics, Inc.",
"company_website_url": "orizuru-therapeutics.com",
"company_linkedin_url": "https://www.linkedin.com/company/orizuru-therapeutics-inc",
"event_type": "funding",
"funding_amount": 300000000,
"funding_currency": "JPY",
"funding_stage": null,
"message": "*Orizuru Therapeutics, Inc., a Kyoto University-originated biotech developing iPS cell-derived therapies for heart failure and type 1 diabetes, received an additional investment of approximately JPY 300 million from Kyoto University Innovation Capital Co., Ltd.*"
}